BTD

5-BROMOTHIENYLDEOXYURIDINE

Find entries where: BTD

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	5-BROMOTHIENYLDEOXYURIDINE
Identifiers	5-(5-bromothiophen-2-yl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
Formula	C₁₃ H₁₃ Br N₂ O₅ S
Molecular Weight	389.222
Type	NON-POLYMER
Isomeric SMILES	c1cc(sc1C2=CN(C(=O)NC2=O)[C@H]3C[C@@H]([C@H](O3)CO)O)Br
InChI	InChI=1S/C13H13BrN2O5S/c14-10-2-1-9(22-10)6-4-16(13(20)15-12(6)19)11-3-7(18)8(5-17)21-11/h1-2,4,7-8,11,17-18H,3,5H2,(H,15,19,20)/t7-,8+,11+/m0/s1
InChIKey	IGUZFFOBAZCVRK-VAOFZXAKSA-N

Chemical Details
Formal Charge	0
Atom Count	35
Chiral Atom Count	3
Bond Count	37
Aromatic Bond Count	5

Drug Info: DrugBank

DrugBank ID	DB03804
Name	5-Bromothienyldeoxyuridine
Groups	experimental
Synonyms	5-Bromothienyldeoxyuridine

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Thymidine kinase	MASYPCHQHASAFDQAARSRGHSNRRTALRPRRQQEATEVRLEQKMPTLL...	unknown	ligand

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682